|
Market Closed -
NYSE
04:01:32 2026-11-06 pm EST
|
After hours 08:00:00 pm | |||
| 29.39 USD | -0.20% |
|
29.32 | -0.22% |
| Nov. 06 | GSK, Moderna settle patent dispute over Moderna COVID, RSV shots | RE |
| Nov. 06 | Moderna Raises Full-Year Revenue Growth Outlook Following Surprise Third-Quarter Profit | MT |
| Market Cap | 168B 150B 137B 125B 236B 15,747B 244B 1,655B 660B 8,402B 629B 615B 26,525B | P/E 2026 * |
17.7x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 217B 195B 178B 162B 306B 20,403B 316B 2,144B 855B 10,887B 815B 797B 34,368B | EV / Sales 2026 * |
3.44x | EV / Sales 2027 * | 3.41x |
| Free-Float |
59.05% | Yield 2026 * |
5.85% | Yield 2027 * | 5.9% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PFE | Delayed | |
CBOE
| PFE | Real-time | |
|
Tradegate
| PFE | Real-time | |
|
Xetra
| PFE | Delayed | |
|
Boerse Muenchen
| PFE | Real-time | |
|
CBOE
| PFEs | Real-time | |
|
London S.E.
| PFZ | Delayed | |
|
Mexican S.E.
| PFE * | End-of-day quote | |
|
Deutsche Boerse AG
| PFE | Delayed | |
|
Kazakhstan S.E.
| PFE_KZ | End-of-day quote | |
|
Borsa Italiana
| 1PFE | End-of-day quote | |
|
Bulgaria S.E.
| PFE | End-of-day quote | |
|
Börse Stuttgart
| PFE | Delayed | |
|
CBOE
| PFZ | Real-time | |
|
Wiener Boerse
| PFE | End-of-day quote | |
|
Bolsa De Valores De Colombia
| PFECO | End-of-day quote | |
|
Swiss Exchange
| PFE | Delayed | |
|
Lima
| PFEUS | End-of-day quote | |
|
Santiago S.E.
| PFECL | End-of-day quote | |
|
Santiago S.E.
| PFE | End-of-day quote | |
|
Swiss Exchange
| PFE | Delayed |
Last Transcript: Pfizer Inc.
| 1 day | -0.22% | ||
| 1 week | -3.70% | ||
| Current month | -3.70% | ||
| 1 month | +6.87% | ||
| 3 months | +12.18% | ||
| 6 months | +10.78% | ||
| Current year | +18.03% |
| 1 week | 28.54 |  | 31.44 |
| 1 month | 27.48 | | 31.44 |
| Current year | 23.62 | | 31.44 |
| 1 year | 23.62 | | 31.44 |
| 3 years | 20.92 | | 31.54 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/15/26 | Free | Chief Executive Officer | 20 | 0.0000% | ||
| 10/13/26 | Free | Chief Executive Officer | 71 | 0.0000% | ||
| 9/30/26 | Free | Chief Executive Officer | 21 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.20% | -3.70% | +18.27% | -5.74% | 168B | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,206B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 665B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 515B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 381B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 307B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 289B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 207B | |
| Average | -0.10% | -1.41% | +38.19% | +68.33% | 434.73B | |
| Weighted average by Cap. | -0.05% | -1.89% | +41.31% | +84.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.02B 56.52B 51.66B 47.15B 88.84B 5,924B 91.64B 623B 248B 3,161B 237B 231B 9,978B | 60.7B 54.44B 49.75B 45.42B 85.57B 5,706B 88.27B 600B 239B 3,044B 228B 223B 9,611B |
| Net income | 8.7B 7.8B 7.13B 6.51B 12.26B 817B 12.65B 85.92B 34.26B 436B 32.64B 31.94B 1,377B | 11.34B 10.17B 9.3B 8.49B 15.99B 1,066B 16.49B 112B 44.68B 569B 42.57B 41.66B 1,796B |
| Net Debt | 49.53B 44.42B 40.6B 37.06B 69.83B 4,656B 72.03B 489B 195B 2,484B 186B 182B 7,843B | 39.76B 35.66B 32.59B 29.75B 56.05B 3,737B 57.81B 393B 157B 1,994B 149B 146B 6,295B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | $29.39 | -1.64% | 48,319,585 |
| 26-11-05 | $29.88 | -2.96% | 53,051,021 |
| 26-11-04 | $30.79 | +2.63% | 49,921,028 |
| 26-11-03 | $30.00 | -2.18% | 53,059,339 |
| 26-11-02 | $30.67 | +0.49% | 50,818,539 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
